|
Getting your Trinity Audio player ready...
|
Sept. 25, 2026 From AI data centers and Alzheimer’s research to drug safety testing and humanoid robots, six small-cap companies are approaching developments that could shape their next phase of growth.
Hyperscale Data, Inc. (NYSE American: GPUS) is developing its Michigan AI data center with backing from Ault & Company, which says it has invested $55 million directly through convertible preferred stock. Ault and its affiliates beneficially own approximately 62% of GPUS. The data center’s initial master services agreement covers 20 megawatts of AI compute capacity, with a customer option to expand to 52 megawatts. Hyperscale Data estimates the initial deployment could produce more than $1.2 billion over the agreement’s maximum 20-year term if it remains in effect. That amount is potential future revenue, with deployment and contract performance still ahead.
IGC Pharma, Inc. (NYSE: IGC) is approaching several key Alzheimer’s and AI catalysts after Ascendiant Capital Markets raised its 12-month price target while maintaining a BUY rating. The Company’s lead Alzheimer’s drug candidate, IGC-AD1, is advancing through the Phase 2 CALMA trial for agitation associated with Alzheimer’s dementia, with topline results anticipated in Q4 2026following previously reported positive interim findings. IGC is also developing AI-enabled technologies for Alzheimer’s research and drug development, adding another potential growth driver as the Company enters 2027. Ascendiant cited continued clinical progress and upcoming milestones in raising its target, positioning IGC as a closely watched emerging Alzheimer’s biotechnology and AI healthcare company.
VivoSim Labs, Inc. (NASDAQ: VIVS) is developing 3D human tissue models and AI-based tools intended to identify drug safety risks earlier in development. The company reported approximately 91% predictive accuracy for its NAMkind™ Liver model against clinical liver injury outcomes in a 92-compound dataset. VivoSim also received a $5 million milestone payment from Eli Lilly and Company (NYSE: LLY) tied to a previously divested drug program, with additional milestones possible.
Onconetix Inc. (NASDAQ: ONCO) is drawing attention after SRX Global Inc. (NYSE American: SRXH) disclosed a new investment in the company while liquidating portfolio holdings in Vistagen Therapeutics (NASDAQ: VTGN) and Greenland Mines (NASDAQ: GRML). Onconetix has agreed to acquire Realbotix LLC, whose Vinci AI Vision System places cameras and tracking lenses inside humanoid robots’ eyes to recognize users and objects, detect motion and assess facial expressions. The system is designed to use those visual cues with large language models to adapt a robot’s conversation, giving investors a robotics development to watch as Onconetix works toward completing the acquisition.
SU Group Holdings Ltd. (NASDAQ: SUGP)received exclusive rights to distribute HDX’s TRACELINE PX3 portable X-ray system in Hong Kong and Macau. The product expands its security and inspection offerings following a separate distribution partnership with Germany’s GEZE.
Fathom Holdings Inc. (NASDAQ: FTHM) and Neighborhood Intelligence, Inc. (NASDAQ: NXH)are exploring a transaction under which NXH would contribute digital asset interests, including its approximately 38.8% direct and indirect stake in tZERO, to Fathom. The companies propose assigning at least $130 million in value to the contributed assets. The revised transaction remains a proposal.
About the Companies
The companies featured operate across AI infrastructure, biotechnology, drug development tools, robotics, security services, real estate and digital assets.
About The Street Reports
The Street Reports (TSR) is a financial media awareness platform focused on emerging-growth, small-cap, micro-cap and nano-cap companies. The Street Reports publishes and distributes market-focused content across financial news, media and digital channels, providing companies with expanded visibility and exposure to a broad audience of readers and market participants.